FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to resuscitation and rehabilitation, and can be used to predict the risk of an unfavourable outcome in a chronic critical condition complicated by pneumonia. Determining the neutrophil-to-lymphocyte count (NLC) per unit volume. DNA is recovered from peripheral venous blood. A variant rs1058427 of the AQP4 gene is determined. If the genotype GG rs1058427 and the NLC value are more than 4, a high risk of an unfavourable outcome in the patient is predicted.
EFFECT: method enables predicting the risk of an unfavourable outcome in a chronic critical condition, including as a result of cerebral accidents, complicated by pneumonia, by determining a cellular marker NLC and a molecular marker – a variant rs1058427 of the AQP4 gene.
1 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING INFECTIOUS COMPLICATIONS OF CRITICAL CONDITION | 2020 |
|
RU2743453C1 |
| METHOD FOR PREDICTING DEVELOPMENT OF PULMONARY HYPERTENSION IN PLEURAL EMPYEMA | 2023 |
|
RU2825056C1 |
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF FATAL OUTCOME IN 14-DAY PERIOD OF ACUTE ISCHEMIC STROKE OF THE BRAIN | 2020 |
|
RU2748685C1 |
| METHOD FOR PREDICTING THE RISK OF HOSPITAL MORTALITY IN PATIENTS WITH A NEW CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2780522C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN SARS-CoV-2-ASSOCIATED PNEUMONIA | 2023 |
|
RU2825705C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CYTOKINE STORM ASSOCIATED WITH COVID-19 | 2022 |
|
RU2825710C2 |
| METHOD FOR PREDICTION OF SURVIVAL OF PATIENTS WITH ISCHEMIC STROKE ASSOCIATED WITH COVID-19 | 2023 |
|
RU2794342C1 |
| METHOD FOR PERSONIFIED PREDICTION OF FATAL OUTCOMES OF COVID-19-ASSOCIATED PNEUMONIA IN ELDERLY AND SENILE PATIENTS | 2023 |
|
RU2817106C1 |
